Analyst maintains Buy on $RNG, lowers price target to $28 due to lower revenue projections for fiscal 2025 and 2026, but highlights new products and potential for $100M ARR in 2025.
Latest Ratings for RNG
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Evercore ISI Group | Maintains | Outperform | |
| Feb 2022 | JP Morgan | Maintains | Overweight | |
| Feb 2022 | Needham | Maintains | Buy |
